Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Peroxide-Induced Oxidative Modification of Hemoglobin.

Vasilyeva AD, Yurina LV, Bugrova AE, Indeykina MI, Azarova DY, Bychkova AV, Akzhigitova KI, Kononikhin AS, Nikolaev EN, Rosenfeld MA.

Dokl Biochem Biophys. 2019 May;486(1):197-200. doi: 10.1134/S1607672919030116. Epub 2019 Jul 31.

PMID:
31367820
2.

Hypochlorite-Induced Oxidative Modification of Fibrinogen.

Yurina LV, Vasilyeva AD, Bugrova AE, Indeykina MI, Kononikhin AS, Nikolaev EN, Rosenfeld MA.

Dokl Biochem Biophys. 2019 May;484(1):37-41. doi: 10.1134/S1607672919010101. Epub 2019 Apr 22.

PMID:
31012009
3.

Binding of Coagulation Factor XIII Zymogen to Activated Platelet Subpopulations: Roles of Integrin αIIbβ3 and Fibrinogen.

Kotova YN, Podoplelova NA, Obydennyy SI, Kostanova EA, Ryabykh AA, Demyanova AS, Biriukova MI, Rosenfeld MA, Sokolov AV, Chambost H, Kumskova MA, Ataullakhanov FI, Alessi MC, Panteleev MA.

Thromb Haemost. 2019 Jun;119(6):906-915. doi: 10.1055/s-0039-1683912. Epub 2019 Apr 1.

PMID:
30934104
4.

Study of Human Fibrinogen Oxidative Modification using Differential Scanning Calorimetry.

Gorobets MG, Wasserman LA, Bychkova AV, Konstantinova ML, Plaschina IG, Rosenfeld MA.

Dokl Biochem Biophys. 2018 May;480(1):146-148. doi: 10.1134/S1607672918030067. Epub 2018 Jul 14.

PMID:
30008096
5.

Oxidation of proteins: is it a programmed process?

Rosenfeld MA, Vasilyeva AD, Yurina LV, Bychkova AV.

Free Radic Res. 2018 Jan;52(1):14-38. doi: 10.1080/10715762.2017.1402305. Epub 2017 Dec 28. Review.

PMID:
29284315
6.

Modification of human serum albumin under induced oxidation.

Gorobets MG, Wasserman LA, Vasilyeva AD, Bychkova AV, Pronkin PG, Bugrova AE, Indeykina MI, Shilkina NG, Konstantinova ML, Kononikhin AS, Nikolaev EN, Rosenfeld MA.

Dokl Biochem Biophys. 2017 May;474(1):231-235. doi: 10.1134/S1607672917030218. Epub 2017 Jul 20.

PMID:
28726091
7.

Oxidation-induced modification of the fibrinogen polypeptide chains.

Bychkova AV, Vasilyeva AD, Bugrova AE, Indeykina MI, Kononikhin AS, Nikolaev EN, Konstantinova ML, Rosenfeld MA.

Dokl Biochem Biophys. 2017 May;474(1):173-177. doi: 10.1134/S1607672917030115. Epub 2017 Jul 20.

PMID:
28726089
8.

Modification of the catalytic subunit of plasma fibrin-stabilizing factor under induced oxidation.

Vasilyeva AD, Bychkova AV, Bugrova AE, Indeykina MI, Chikunova AP, Leonova VB, Kostanova EA, Biryukova MI, Konstantinova ML, Kononikhin AS, Nikolaev EN, Rosenfeld MA.

Dokl Biochem Biophys. 2017 Jan;472(1):40-43. doi: 10.1134/S160767291701015X. Epub 2017 Apr 19.

PMID:
28421433
9.

The oxidative modification of cellular fibrin-stabilizing factor.

Rosenfeld MA, Shchegolikhin AN, Leonova VB, Kostanova EA, Biryukova MI, Bychkova AV, Konstantinova ML, Vasilyeva AD.

Dokl Biochem Biophys. 2016 Mar;467(1):128-31. doi: 10.1134/S1607672916020149. Epub 2016 May 20.

PMID:
27193716
10.

The strengthening role of D:D interactions in fibrin self-assembly under oxidation.

Rosenfeld MA, Leonova VB, Bychkova AV, Kostanova EA, Biryukova MI, Sultimova NB, Konstantinova ML, Gorobets MG.

Dokl Biochem Biophys. 2016;466:28-31. doi: 10.1134/S1607672916010087. Epub 2016 Mar 31.

PMID:
27025482
11.

Fibrin self-assembly is adapted to oxidation.

Rosenfeld MA, Bychkova AV, Shchegolikhin AN, Leonova VB, Kostanova EA, Biryukova MI, Sultimova NB, Konstantinova ML.

Free Radic Biol Med. 2016 Jun;95:55-64. doi: 10.1016/j.freeradbiomed.2016.03.005. Epub 2016 Mar 9.

PMID:
26969792
12.

Longitudinal orientation of cross-linked polypeptide γ chains in fibrin fibrils.

Rosenfeld MA, Leonova VB, Bychkova AV, Kostanova EA, Biryukova MI.

Dokl Biochem Biophys. 2015;464:286-9. doi: 10.1134/S1607672915050051. Epub 2015 Oct 31.

PMID:
26518549
13.

Nature of active intermediate particles formed during ozone-induced oxidation.

Rosenfeld MA, Razumovskii SD, Shchegolikhin AN, Konstantinova ML, Sultimova NB, Kozachenko AI, Nagler LG, Bychkova AV, Leonova VB.

Dokl Biochem Biophys. 2015;461:139-41. doi: 10.1134/S1607672915020180. Epub 2015 May 5. No abstract available.

PMID:
25937234
14.

Covalent structure of single-stranded fibrin oligomers cross-linked by FXIIIa.

Rosenfeld MA, Leonova VB, Shchegolikhin AN, Bychkova AV, Kostanova EA, Biryukova MI.

Biochem Biophys Res Commun. 2015 May 29;461(2):408-12. doi: 10.1016/j.bbrc.2015.04.052. Epub 2015 Apr 18.

PMID:
25896761
15.

Ozone-induced oxidative modification of fibrinogen: role of the D regions.

Rosenfeld MA, Shchegolikhin AN, Bychkova AV, Leonova VB, Biryukova MI, Kostanova EA.

Free Radic Biol Med. 2014 Dec;77:106-20. doi: 10.1016/j.freeradbiomed.2014.08.018. Epub 2014 Sep 16.

PMID:
25224034
16.

Ozone-induced oxidative modification of fibrinogen molecules.

Rosenfeld MA, Shchegolikhin AN, Bychkova AV, Leonova VB, Biryukova MI, Kostanova EA, Konstantinova ML.

Biochemistry (Mosc). 2013 Oct;78(10):1171-9. doi: 10.1134/S000629791310012X.

PMID:
24237152
17.

Oxidative modification of fibrinogen molecules.

Rosenfeld MA, Shegolihin AN, Bychkova AV, Leonova VB, Biryukova MI, Kostanova EA, Konstantinova ML.

Dokl Biochem Biophys. 2013 Sep;452(1):255-8. doi: 10.1134/S160767291305013X. Epub 2013 Oct 23. No abstract available.

PMID:
24150586
18.

Ozone-induced oxidative modification of plasma fibrin-stabilizing factor.

Rosenfeld MA, Bychkova AV, Shchegolikhin AN, Leonova VB, Biryukova MI, Kostanova EA.

Biochim Biophys Acta. 2013 Dec;1834(12):2470-9. doi: 10.1016/j.bbapap.2013.08.001. Epub 2013 Aug 12.

PMID:
23948453
19.

Free-radical oxidation of plasma fibrin-stabilizing factor.

Rosenfeld MA, Shegolihin AN, Bychkova AV, Leonova VB, Kostanova EA, Biryukova MI, Razumovskii SD, Konstantinova ML.

Dokl Biochem Biophys. 2012 Sep-Oct;446:213-6. doi: 10.1134/S1607672912050018. Epub 2012 Nov 7. No abstract available.

PMID:
23132711
20.

Self-assembly of soluble unlinked and cross-linked fibrin oligomers.

Rosenfeld MA, Leonova VB, Biryukova MI, Vasileva MV.

Biochemistry (Mosc). 2011 Oct;76(10):1155-63. doi: 10.1134/S0006297911100099.

PMID:
22098241
21.

The structure of soluble fibrin oligomers.

Rosenfeld MA, Leonova VB, Biryukova MI, Vasileva MV.

Dokl Biochem Biophys. 2011 Sep-Oct;440:203-6. doi: 10.1134/S1607672911050024. Epub 2011 Nov 19. No abstract available.

PMID:
22095118
22.

Oxidized modification of fragments D and E from fibrinogen induced by ozone.

Rosenfeld MA, Leonova VB, Shchegolikhin AN, Razumovskii SD, Konstantinova ML, Bychkova AV, Kovarskii AL.

Biochemistry (Mosc). 2010 Oct;75(10):1285-93.

PMID:
21166647
23.

Enzymatic crosslinking of oxidized fibrinogen.

Rosenfeld MA, Leonova VB, Konstantinova ML, Razumovskii SD.

Dokl Biochem Biophys. 2009 Jan-Feb;424:20-3. No abstract available.

PMID:
19341100
24.

Self-assembly of fibrin monomers and fibrinogen aggregation during ozone oxidation.

Rosenfeld MA, Leonova VB, Konstantinova ML, Razumovskii SD.

Biochemistry (Mosc). 2009 Jan;74(1):41-6.

PMID:
19232047
25.

NIDCD/VA hearing aid clinical trial and follow-up: coupler and real-ear measurement.

Peek BF, Rosenfeld MA, Bratt GW, Williams DW.

J Am Acad Audiol. 2007 Apr;18(4):282-91.

PMID:
17580724
26.

NIDCD/VA hearing aid clinical trial and follow-up: background.

Bratt GW, Rosenfeld MA, Williams DW.

J Am Acad Audiol. 2007 Apr;18(4):274-81.

PMID:
17580723
27.

Coupler and real-ear measurement of hearing aid gain and output in the NIDCD/VA Hearing Aid Clinical Trial.

Bratt GW, Rosenfeld MA, Peek BF, Kang J, Williams DW, Larson V.

Ear Hear. 2002 Aug;23(4):308-15.

PMID:
12195173
28.

Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene.

Loftus SK, Morris JA, Carstea ED, Gu JZ, Cummings C, Brown A, Ellison J, Ohno K, Rosenfeld MA, Tagle DA, Pentchev PG, Pavan WJ.

Science. 1997 Jul 11;277(5323):232-5.

29.

Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis.

Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, Gu J, Rosenfeld MA, Pavan WJ, Krizman DB, Nagle J, Polymeropoulos MH, Sturley SL, Ioannou YA, Higgins ME, Comly M, Cooney A, Brown A, Kaneski CR, Blanchette-Mackie EJ, Dwyer NK, Neufeld EB, Chang TY, Liscum L, Strauss JF 3rd, Ohno K, Zeigler M, Carmi R, Sokol J, Markie D, O'Neill RR, van Diggelen OP, Elleder M, Patterson MC, Brady RO, Vanier MT, Pentchev PG, Tagle DA.

Science. 1997 Jul 11;277(5323):228-31.

30.

Substantial narrowing of the Niemann-Pick C candidate interval by yeast artificial chromosome complementation.

Gu JZ, Carstea ED, Cummings C, Morris JA, Loftus SK, Zhang D, Coleman KG, Cooney AM, Comly ME, Fandino L, Roff C, Tagle DA, Pavan WJ, Pentchev PG, Rosenfeld MA.

Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7378-83.

31.

Human artificial chromosomes get real.

Rosenfeld MA.

Nat Genet. 1997 Apr;15(4):333-5. No abstract available.

PMID:
9090375
32.

Functional human CFTR produced by stable Chinese hamster ovary cell lines derived using yeast artificial chromosomes.

Mogayzel PJ Jr, Henning KA, Bittner ML, Novotny EA, Schwiebert EM, Guggino WB, Jiang Y, Rosenfeld MA.

Hum Mol Genet. 1997 Jan;6(1):59-68.

PMID:
9002671
33.

Gene therapy for cystic fibrosis.

Rosenfeld MA, Collins FS.

Chest. 1996 Jan;109(1):241-52. Review. No abstract available. Erratum in: Chest 1996 Jun;109(6):1668.

PMID:
8549191
34.

Gene therapy for the respiratory manifestations of cystic fibrosis.

Korst RJ, McElvaney NG, Chu CS, Rosenfeld MA, Mastrangeli A, Hay J, Brody SL, Eissa NT, Danel C, Jaffe HA, et al.

Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 2):S75-87. Review.

PMID:
7533609
36.

Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis.

Crystal RG, McElvaney NG, Rosenfeld MA, Chu CS, Mastrangeli A, Hay JG, Brody SL, Jaffe HA, Eissa NT, Danel C.

Nat Genet. 1994 Sep;8(1):42-51.

PMID:
7527271
37.
38.
39.

Gene therapy for pulmonary diseases.

Rosenfeld MA, Ronald G, Crystal RG.

Pathol Biol (Paris). 1993 Oct;41(8):677-80. Review.

PMID:
8290311
40.

Protection of human endothelial cells from oxidant injury by adenovirus-mediated transfer of the human catalase cDNA.

Erzurum SC, Lemarchand P, Rosenfeld MA, Yoo JH, Crystal RG.

Nucleic Acids Res. 1993 Apr 11;21(7):1607-12.

41.

Adenovirus-mediated augmentation of cell transfection with unmodified plasmid vectors.

Yoshimura K, Rosenfeld MA, Seth P, Crystal RG.

J Biol Chem. 1993 Feb 5;268(4):2300-3.

42.

Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer.

Mastrangeli A, Danel C, Rosenfeld MA, Stratford-Perricaudet L, Perricaudet M, Pavirani A, Lecocq JP, Crystal RG.

J Clin Invest. 1993 Jan;91(1):225-34.

43.

Adenovirus-mediated in vivo gene transfer and expression in normal rat liver.

Jaffe HA, Danel C, Longenecker G, Metzger M, Setoguchi Y, Rosenfeld MA, Gant TW, Thorgeirsson SS, Stratford-Perricaudet LD, Perricaudet M, et al.

Nat Genet. 1992 Aug;1(5):372-8.

PMID:
1302034
44.

Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer.

Yoshimura K, Rosenfeld MA, Nakamura H, Scherer EM, Pavirani A, Lecocq JP, Crystal RG.

Nucleic Acids Res. 1992 Jun 25;20(12):3233-40.

45.

In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.

Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Dalemans W, Fukayama M, Bargon J, Stier LE, Stratford-Perricaudet L, et al.

Cell. 1992 Jan 10;68(1):143-55.

PMID:
1370653
46.

Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo.

Rosenfeld MA, Siegfried W, Yoshimura K, Yoneyama K, Fukayama M, Stier LE, Pääkkö PK, Gilardi P, Stratford-Perricaudet LD, Perricaudet M, et al.

Science. 1991 Apr 19;252(5004):431-4.

PMID:
2017680

Supplemental Content

Loading ...
Support Center